What has truly transformed endoscopy over the past decades?

In this first part of a two-part conversation, host Egle Dieninyte sits down with Professor Nageshwar Reddy, one of the most influential pioneers in modern therapeutic endoscopy, to reflect on how the field has evolved — and where it is heading next.

From the transition from rigid to fibreoptic endoscopy, to the introduction of video systems that reshaped team dynamics in the endoscopy suite, Professor Reddy explains why some of the most powerful innovations were not necessarily the most glamorous ones.

The discussion also explores:
• Disposable scopes and environmental responsibility
• Antibiotic resistance and global practice differences
• The role of passion and compassion in medicine
• Regenerative endoscopy and stem cell applications
• The story behind the “Nagi stent”

Beyond technology, this episode offers a personal perspective on success, mentorship, and what it truly means to be a good endoscopist.

🎧 Listen now to Part 1 — and stay tuned for Part 2, which will be released in a week from now on the 4th of March.

- What happens when optical diagnosis and histology don’t align?
- Does better polyp detection always mean better outcomes?
- And how should AI, quality metrics and surveillance intervals really shape daily endoscopy practice?

In this special episode, we share an unfiltered round-table discussion recorded during the UEG Online Course on the impact of polyp detection in colonoscopy. Leading experts Raf Bisschops, Manuele Furnari, Veronique Van der Voort and Pieter Sinonquel debate real-world dilemmas around serrated lesions, pathology discordance, documentation, bowel preparation and the clinical consequences of rising ADRs.

Also watch it as a video podcast on Spotify

Listen now and explore the full course for free (login required) on gutflix.eu: [The impact of polyp detection in colonoscopy](https://gutflix.eu/r/i6GfsYAhus8u)

In this episode of the UEG Podcast, host Pradeep Mundre is joined by David Sanders, Professor of Gastroenterology at Sheffield and one of the world’s leading experts in coeliac disease.
Timed with the recent update of the British Society of Gastroenterology coeliac guidelines, the discussion explores why coeliac disease remains frequently underdiagnosed, even in specialist care. Together, they unpack the latest evidence on serology-based diagnosis, optimal biopsy strategies, potential and seronegative coeliac disease, and when HLA testing is truly useful.
The episode also covers long-term follow-up, the role of repeat biopsies, ultra-short coeliac disease, and emerging non-dietary therapies — including the realistic prospects of a future “pizza pill”.

Check out the newest guidelines on coeliac disease here:https://doi.org/10.1002/ueg2.70119

Immunotherapy might be revolutionising the way we fight GI cancers. In our latest episode, we dive into how this innovative treatment is changing patient outcomes and the role it plays in cancer management. To discuss this, we talked to Jeroen Dekervel, gastroenterologist and oncologist at the UZ Leuven in Belgium. Our host, Pradeep Mundre guides us through the conversation about how tumours develop a resistance to chemotherapy, the quality of life for oncological patients, and why the term "palliative treatment" for cancer patients could use an update.

In this thought-provoking episode of the UEG Podcast, host Egle Dieninyte sits down with organisational psychologist Lina Sopiene to explore one of medicine’s most unspoken challenges — burnout.
Together, they unpack why high-achieving healthcare professionals often equate self-worth with performance, how this mindset fuels exhaustion, and what practical steps can help doctors and nurses reconnect with themselves. From learning to “be a human being, not just a human doing” to managing workplace anger and setting healthy boundaries, this conversation is a candid look at the emotional realities of hospital life.
Lina offers grounded, compassionate insights on self-care, emotional regulation, and the art of saying no — lessons that every healthcare worker can relate to.
Honest, empathetic, and deeply relevant — a must-listen for anyone navigating the pressures of modern medicine.

This episode of the UEG Podcast takes place at the EPC meeting in the summer of 2025. Our host Egle Dieninyte sits down with Professor Marco Del Chiaro, Surgical Oncologist and global lead of the upcoming Guidelines on Pancreatic Cystic Neoplasms.
Tune in as they discuss why a unified, evidence-based approach is essential in this complex field, the challenges of managing cystic pancreatic lesions with limited high-quality data, and the balance between clinical judgement and guideline recommendations.
Professor Del Chiaro also reflects on the limitations of current evidence, the evolving role of biomarkers, and how collaboration across continents may finally help standardise diagnosis, surveillance, and treatment for these patients.
Insightful, candid, and forward-looking — this episode offers a rare behind-the-scenes view into how global consensus in pancreatic disease is built.

In this episode of the UEG Podcast, Mary Phillips and Leigh Donnelly reflect on the highlights of UEG Week 2025 in Berlin from a nursing and allied healthcare perspective.
They discuss the most inspiring sessions from learning through mistakes in “Never Waste a Good Disaster” to the growing focus on sustainability, green endoscopy, and global health. The conversation also touches on caring for trans patients in gastroenterology, tackling fake news in dietetics, and understanding the clinical impact of GLP-1 medications and pancreatic cancer research.
With insights on teamwork, education, and the value of multidisciplinary collaboration, this episode celebrates the essential role of nurses and allied health professionals in advancing digestive health care.

In this episode, UEG's new Scientific Committee chair Jörn Schattenberg and Carolin Schneider, UEG rising start of 2025, recap the standout science from UEG Week 2025 in Berlin. They discuss highlights from the HPB field, including pivotal phase III data on linerixibat for cholestatic pruritus in PBC, advances in MASLD/MASH therapies such as FGF21 analogues and resmetirom, and new insights into liquid biopsy and AI-assisted imaging for pancreatic lesions. The conversation also explores simvastatin’s potential in preventing recurrent pancreatitis and reflects on the value of collaboration, precision medicine, and prospective clinical trials showcased at UEG Week.

In this episode of the UEG Podcast, our host Pradeep Mundre, together with IBD expert Klaartje Bel Kok, explore the latest breakthroughs in IBD presented at UEG Week 2025 in Berlin.

From long-term IL-23 inhibitor data to novel drugs such as Obefazimod and Tulisokibart, the discussion covers key findings that are reshaping IBD management. Bel dives into new insights on JAK inhibitors in pregnancy, the growing role of ultrasound monitoring in IBD, and the challenge of choice overload in treatment decisions.
Tune in for expert reflections on emerging research, collaboration within the IBD community, and the evolving understanding of IBD’s complex aetiology.

Join Julia Mayerle and Francisco X. Real (Paco) as they reflect on the first-ever Digestive Disease Mechanism (DDM) Summit, introduced during UEG Week 2025 in Berlin.
In this special episode, they discuss how the DDM Summit brought together leading scientists and clinicians to explore the mechanisms driving GI cancers — from colorectal to pancreatic and liver cancer. Hear how cutting-edge discoveries in genomics, metabolism, and tumour microenvironment are already shaping translational research and clinical trials.
Julia and Paco also share highlights from the meeting, including exciting poster sessions, emerging collaborations, and their vision for the next DDM Summit focusing on inflammation in GI disease.

- 08:00 The evolution of colitis-associated colorectal cancer Trevor A. Graham (United Kingdom)
- 09:45 Tumour cell plasticity and immune evasion in metastatic colorectal cancer. Eduard Batlle Gomez (Spain)
- 11:45 Cutting the nerve supply to pancreatic cancer Andreas Trumpp (Germany)
- 16:40 Neutrophil-driven inflammation in PDAC progression Dieter Saur (Germany)
- 17:30 Exploring the therapy-associated tumour immune microenvironment across the spectrum of HCC Tom Bird (UK)
- 17:45 Intermittent fasting in MASH and liver cancer Suchira Gallage (Germany)
- 17:50 Metabolic drivers of cancer and obesity-related diseases Guadalupe Sabio (Spain)